The legal action, initiated by the firm Levi & Korsinsky, centers on claims that CEO Eddie Yongming Wu signed Sarbanes-Oxley certifications that omitted critical information about Alibaba’s status as a designated Chinese military company under the FY2025 NDAA. Furthermore, the suit alleges that company filings framed the unauthorized "distillation" of third-party AI models—specifically Anthropic’s Claude—as a hypothetical risk, despite claims that such adversarial activity was already underway.
Financial records indicate significant volatility for Alibaba’s American Depositary Shares (ADS) during the period in question. After reaching a high of $173.68 in October 2025, the stock price experienced sharp declines following disclosures related to the company’s military status and accusations from Anthropic regarding illicit access to its models. By June 25, 2026, shares had fallen to $95.07, representing a decline of roughly 45.26%. Investors seeking to act as lead plaintiff in the Southern District of New York case have until October 5, 2026, to file with the court.
Comments (0)
No comments yet. Be the first!